Growing life-like heart valves, thanks to help from computational modeling

May 09, 2018

Scientists have harnessed the power of computational modeling to design a bioengineered heart valve that emulates the properties of native heart valves. The tissue-engineered heart valve (TEHV) was safe and performed well one year following transplantation into sheep, indicating it may one day offer a therapeutic tool for patients with heart valve conditions. Patients usually receive prosthetic heart valves for valvular heart disease (which remains a major global health burden), yet current prostheses suffer from limited longevity and fail to grow properly in young patients. Researchers have long explored using bioengineering approaches to create living heart valve replacements that can regenerate and remodel themselves to better accommodate the native circulatory system. However, none of the TEHVs under evaluation to date contain the unique properties of native heart valves needed to continuously adapt to changes in blood flow over time. To overcome this hurdle, Maximilian Emmert and colleagues used computational modeling to predict how TEHVs would remodel over time after transplantation - a strategy that allowed them to design a longer-lasting TEHV with improved valve mechanics and tissue structure. Importantly, their model estimated in which directions the valves would stretch to compensate for later remodeling. The authors manufactured the TEHVs from blood vessel cells seeded on polymer mesh structures growing in culture over four weeks, before removing the cellular components and implanting the valves into 11 sheep. MRI imaging revealed that nine of the 11 TEHVs still functioned at the end of the year-long study and remodeled themselves in a similar fashion to native heart valves. In a related Focus, Jonathan Butcher says the study solves a complex outstanding problem and represents, "a critical advance for clinical translation" of TEHV technology.

American Association for the Advancement of Science

Related Transplantation Articles from Brightsurf:

A revolutionary new treatment alternative to corneal transplantation
A new approach in ophthalmology that offers a revolutionary alternative to corneal transplantation has just been developed by researchers and clinicians in North America, Europe, and Oceania.

Fewer complications after organ transplantation
A large international study coordinated by University Hospital Regensburg and Charité - Universitätsmedizin Berlin has demonstrated the safety of new cell therapy approaches for use in kidney transplant recipients.

Elderly patients also benefit from kidney transplantation
So far, kidney transplantation has generally not been offered to elderly patients (>75 years) because of the perioperative risks.

New material will allow abandoning bone marrow transplantation
Scientists from the National University of Science and Technology 'MISIS' developed nanomaterial, which will be able to restore the internal structure of bones damaged due to osteoporosis and osteomyelitis.

Fewer medical tests -- timely listing for transplantation
Younger patients would benefit greatly from kidney transplantation. Their expected remaining lifetime may even be doubled by having a transplant.

Uterus transplantation -- ethically just as problematic as altruistic surrogacy
In 2014, the first child to have been gestated in a donated uterus was born.

Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.

Transplantation followed by antiviral therapy cured hepatitis C
Twenty patients who received kidneys transplanted from hepatitis C virus (HCV)-infected donors experienced HCV cure, good quality of life, and excellent renal function at one year.

The Journal of Heart and Lung Transplantation: 50 years of heart transplantation progress
This month marks the 50th anniversary of the world's first human heart transplant performed at Groote Schuur Hospital in Cape Town by South African surgeon, Christiaan Barnard.

Older donor lungs should be considered for transplantation
With a scarcity of lungs available for transplantation, the use of lungs from donors older than age 60 has been shown to achieve reasonable outcomes and should be considered as a viable option, according to research published online today in The Annals of Thoracic Surgery.

Read More: Transplantation News and Transplantation Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to